Purpose To compare structural outcomes, visual function, refraction, and frequency of follow-up
for infants with type 1 retinopathy of prematurity in zone I or zone II posterior treated with …

PURPOSE: To evaluate the visual functions of children with hereditary dislocated lenses
after within-the-bag lensectomy surgery and to report the results of 18 eyes with a follow-up …

Objective To compare neurodevelopmental and visual outcomes in preterm infants treated
with intravitreal bevacizumab (IVB) to laser ablation at 18–24 months corrected age. Study …

Objective To compare costs of 2 screening modalities for retinopathy of prematurity (ROP):
telemedicine imaging with remote interpretation versus in-person binocular indirect …

Purpose To determine the prevalence of treatment-related ocular complications and disease
progression following treatment for retinopathy of prematurity (ROP). Methods This was a …

Off-label intravitreal injection of bevacizumab, an anti-vascular endothelial growth factor agent,
has been shown to be an effective treatment for type 1 retinopathy of prematurity (ROP) in …

Telemedicine is increasingly being used in ophthalmology for diagnosis, education and
research. Combined with digital imaging, telemedicine has been successful in screening for …

This retrospective case series assessed the influence of unilateral intravitreal bevacizumab (IVB)
for unilateral type 1 retinopathy of prematurity (ROP) on macular thickness and foveal …

Retinopathy of prematurity (ROP) is a disorder of abnormal retinal vascular development in
preterm infants and a significant cause of global blindness. The Early Treatment of …

Importance To evaluate the natural history and outcomes of infants with stage‐3 retinopathy
of prematurity (ROP) persisting beyond 40‐weeks of post‐menstrual age (PMA). …